Ampac Fine Chemicals Signs API Manufacturing Deal

Ampac Fine Chemicals (AFC; Rancho Cordova, CA), a subsidiary of American Pacific (Las Vegas, NV), says it has signed an agreement with Chimerix (Durham, NC), to validate at commercial scale the manufacturing process for the active pharmaceutical ingredient (API) in Chimerix’s antiviral drug candidate, CMX001, which is being developed for the prevention and treatment of smallpox. Chimerix will provide the investigational drug product under a contract with the U.S. government agency, biomedical advanced research and development authority. The validation...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers